Xi Meow Cattery Receives Singapore SME 500 Award 2025 by ATC

Xi Meow Cattery Receives Singapore SME 500 Award 2025 by ATC

SINGAPORE, May 19, 2025 /PRNewswire/ -- Xi Meow Cattery, a leading provider of pedigreed kittens for sale in Singapore, is proud to announce that it has been awarded the prestigious Singapore SME 500 Award 2025 by the Association of Trade and...

Intalight™ Receives CE Mark for Its Progressive DREAM OCT™ Swept Source Imaging

Intalight™ Receives CE Mark for Its Progressive DREAM OCT™ Swept Source Imaging

SAN JOSE, Calif. and SHANGHAI, May 15, 2025 /PRNewswire/ -- Intalight™ , a company that develops advanced ophthalmic technologies and a leader in Optical Coherence Tomography (OCT) today announced it has received CE mark for its DREAM OCT™ platform....

GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California

GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California

YONGIN, South Korea, May 14, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that its U.S. subsidiary, ABO Holdings, has received FDA approval for its plasma collection center located in Calexico, California....

China Liberal Education Holdings Limited Receives Staff Determination Notice from Nasdaq and Plans to Appeal

China Liberal Education Holdings Limited Receives Staff Determination Notice from Nasdaq and Plans to Appeal

BEIJING, May 13, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational...

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

IASO Bio Receives Orphan Drug Designation from the Saudi Food and Drug Authority for Equecabtagene Autoleucel

SHANGHAI, NANJING, China and SAN FRANCISCO, May 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and...

MUNIK Receives DEKRA's First ISO/PAS 8800 Certificate for Automotive AI Safety Development Process

MUNIK Receives DEKRA's First ISO/PAS 8800 Certificate for Automotive AI Safety Development Process

SHANGHAI, April 30, 2025 /PRNewswire/ -- MUNIK, a leading automotive safety technology firm, has been awarded the world's first ISO/PAS 8800 certification by DEKRA, Germany's largest independent testing and certification organization. This milestone...

EP Cube Receives Prestigious 2025 iF Design Award and Gold at the 2025 MUSE Design Awards

EP Cube Receives Prestigious 2025 iF Design Award and Gold at the 2025 MUSE Design Awards

KITCHENER, ON, April 29, 2025 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that its residential energy storage system, EP Cube, has won the prestigious 2025 iF Design Award and Gold at the...

Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

HONG KONG, April 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from the National Medical Products...

Weichai Wins SBR Manufacturing Award 2025 for Advancing Efficiency and Green Innovation

Weichai Wins SBR Manufacturing Award 2025 for Advancing Efficiency and Green Innovation

SINGAPORE, April 25, 2025 /PRNewswire/ -- World-leading engine manufacturer Weichai has received the 2025 Manufacturing Award at the Singapore Business Review (SBR) International Business Awards. The accolade recognizes the company's breakthroughs...

CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

CGBIO Receives FDA IDE Approval for NOVOSIS PUTTY, Advancing Toward U.S. Market Entry

- The bone graft incorporating rhBMP-2 has received FDA IDE approval for a pivotal clinical trial in spinal fusion - Positioned for global expansion in $750M spinal bone graft market SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- CGBIO(CEO Hyun...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • menu
    menu